A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers

INTRODUCTION: The aim of this study was to compare the efficacy and toxicity of dicycloplatin plus paclitaxel with those of carboplatin plus paclitaxel as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC). MATERIAL AND METHODS: In this study, 240 NSCLC patients with...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Liu, Ke-Jun, Guan, Zhong-Zhen, Liang, Ying, Yang, Xu-Qing, Peng, Jin, Huang, He, Shao, Qing-Xiang, Wang, Meng-Zhao, Zhu, Yun-Zhong, Wu, Chang-Ping, Wang, Shao-Bin, Xiong, Jian-Ping, Bai, Yu-Xian, Yu, Shi-Ying, Zhang, Yang, Hu, Xiao-Hua, Feng, Ji-Feng, Wu, Shi-Xiu, Jiao, Shun-Chang, Zhou, Cai-Cun, Wang, Jie, Wu, Hai-Ying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Termedia Publishing House 2014
Soggetti:
Clinical Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4175772/
https://ncbi.nlm.nih.gov/pubmed/25276156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/aoms.2014.44862
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi